BRD2 and acute lymphoblastic leukemia: Thus, the genotypic distribution of these markers was compared between the Amerindian populations investigated in this study (NAT) and leukemic patients (ALL_NAT) with an average of 50% of Amerindian genetic ancestry (see Supplementary Table 1).